Hetian Bai
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Extracellular vesicles in disease
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Bone Metabolism and Diseases
Papers in
-
- Circular RNAs in diseases 3
- Angiogenesis and VEGF in Cancer 1
- Ubiquitin and proteasome pathways 1
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Kexin Lei (4 shared papers)Fei Huang (2 shared papers)Jing Li (5 shared papers)Qianming Chen (5 shared papers)Jiang Zhou (1 shared paper)Xikun Zhou (1 shared paper)Jiongke Wang (2 shared papers)Changqing Xie (1 shared paper)
- Journals
- Acta Biomaterialia (1 paper)Cancer Letters (1 paper)Cellular Oncology (1 paper)Frontiers in Oncology (1 paper)Chemical Communications (1 paper)
- Partner nations
- ChinaNetherlandsUnited Kingdom
In The Last Decade
Hetian Bai
9 papers receiving 291 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 157
- Molecular Biology 219
- Periodontics 4
- Oral Surgery 6
- Genetics 9
Countries citing papers authored by Hetian Bai
This map shows the geographic impact of Hetian Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hetian Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hetian Bai more than expected).
Fields of papers citing papers by Hetian Bai
This network shows the impact of papers produced by Hetian Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hetian Bai. The network helps show where Hetian Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Hetian Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 89 | |
| 2 | 2019 | 81 | |
| 3 | 2020 | 30 | |
| 4 | 2021 | 28 | |
| 5 | 2018 | 28 | |
| 6 | 2022 | 21 | |
| 7 | 2020 | 7 | |
| 8 | 2022 | 6 | |
| 9 | 2020 | 1 | |
| 10 | 2025 | 0 |
About Hetian Bai
Hetian Bai is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Oral Surgery, having authored 10 papers that have together received 291 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), MicroRNA in disease regulation (3 papers), Bone Tissue Engineering Materials (2 papers), Mesenchymal stem cell research (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (157 citations), Molecular Biology (219 citations), Periodontics (4 citations), Oral Surgery (6 citations) and Genetics (9 citations). Hetian Bai has collaborated with scholars based in China, Netherlands and United Kingdom. Frequent co-authors include Kexin Lei, Fei Huang, Jing Li, Qianming Chen, Jiang Zhou, Xikun Zhou, Jiongke Wang, Changqing Xie, Zihao Wei and Yu Xiao. Their work appears in journals such as Acta Biomaterialia, Cancer Letters, Cellular Oncology, Frontiers in Oncology and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.